← All organizations

Pharming Group

For profitContributed to NMEWebsite ↗

Also known as: COO Pharming | PHARMING | Pharming Americas BV | Pharming Group N.V. | Pharming Technologies BV | Pharming Technologies B.V.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Apr 29, 2025

Timeline

1980s

Jun 1, 1988
Pharming Group— Founded

2000s

Oct 15, 2006
DNage B.V.— Acquired

2020s

Mar 24, 2023
Leniolisib— Marketing Organization
Mar 24, 2023
Leniolisib— NDA Organization
Mar 24, 2023
Leniolisib— NDA Secondary Org

Drugs by trial phase (6 distinct, 22 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (3 own, 1 via acquisition)

Indications

Studied for

Marketed drugs (2)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

DNage B.V.

Recent trials (27)

NCT06990529Lead sponsorPhase 2Apr 29, 2025
NCT06897358Lead sponsorPhase 2Feb 12, 2025
NCT06549114Lead sponsorPhase 2Oct 21, 2024
NCT05693129Lead sponsorPhase 3Aug 30, 2023
NCT06249997Lead sponsorPhase 3Aug 3, 2023
NCT05438407Lead sponsorPhase 3Aug 31, 2022
NCT05145283CollaboratorPhase 2Feb 28, 2022
NCT04912141Study directorPhase 2Apr 21, 2021
NCT04912141Lead sponsorPhase 2Apr 21, 2021
NCT04530136Lead sponsorPhase 2Nov 30, 2020
NCT04414631CollaboratorPhase 2Jun 30, 2020
NCT03791476CollaboratorPhase 1Jun 21, 2019
NCT02869347CollaboratorPhase 2Jan 1, 2017
NCT02247739Lead sponsorPhase 2Dec 1, 2014
NCT01359969Lead sponsorPhase 2Dec 1, 2011

Details

Founded: Leiden, NL Jun 1, 1988
First NDA: Mar 24, 2023
Last known activity: Apr 29, 2025

Designations held

Orphan drug
Priority review

Notes

--- Pre-folding founded info: 1988-07-01 Leiden NL https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=32943 ---